Incident Chronic Obstructive pulmoNary dIsease Cohort Study (ICONIC)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age35+
SponsorAssistance Publique - Hôpitaux de Paris

About this trial

Chronic Obstructive Pulmonary Disease (COPD), , secondary to smoking, is a major public health issue with very high direct and indirect costs. The impact on the health system of undiagnosed patients, up to 70% of patients, is increasingly documented. However, systematic spirometry screening remains controversial among smokers in the absence of data to link the detection of new patients with improved management and clinical events and health goals. More generally, there is little data on the evolution of patients in real life once they have entered the care system.

The premise is that with systematic screening in general medicine, it is possible to identify the evolution of newly diagnosed COPD patients, to distinguish the different possible evolutions according to the initial phenotype and the management.

Eligibility criteria

Qualifiers

Age> 35 years

Smoking > 20 PA

Active smoking (cessation < 1 month)

Signature of consent to participate in Phase I of the study

Disqualifiers

Known COPD

Cancer being treated

No affiliation to the social security or other social protection scheme

Pregnant or lactating woman

Trial design

Treatments tested in this trial

  • Exhaustive exploration

Treatment groups

300 Participants
are divided into 1 treatment group